Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Daily News

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

L.A. McKeown

February 11, 2025

News Daily News

DES Best for In-Stent Restenosis, but DCBs Also Viable

Michael O'Riordan

August 13, 2024

News Daily News

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Yael L. Maxwell

June 20, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Daily News

Routine IVUS in Peripheral Interventions Supported by Small RCT

L.A. McKeown

March 09, 2022

News Daily News

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Todd Neale

October 29, 2021

News Daily News

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

L.A. McKeown

October 05, 2021

News Daily News

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

Caitlin E. Cox

September 15, 2021

News Daily News

‘Aggressive’ OCT Strategy for Stent Sizing Noninferior to IVUS: iSIGHT

Caitlin E. Cox

March 18, 2021

News Daily News

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

Michael O'Riordan

March 01, 2021

News Daily News

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

L.A. McKeown

February 18, 2021

News Daily News

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Caitlin E. Cox

October 08, 2020

News Daily News

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

L.A. McKeown

September 17, 2020

News Daily News

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Caitlin E. Cox

July 10, 2020

News Daily News

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Caitlin E. Cox

June 18, 2020

News Daily News

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

Caitlin E. Cox

May 08, 2020

News Daily News

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

L.A. McKeown

March 09, 2020

News Daily News

Balloon-Free PCI for SVG Stenosis Offers Ongoing Advantages: DIVA

Caitlin E. Cox

February 11, 2020

Advertisement

PERFORMANCE II: Low Stroke Rate Seen With All-Inclusive Carotid Stent

DES Best for In-Stent Restenosis, but DCBs Also Viable

P2Y12 Inhibitor Pretreatment Worth Considering in STEMI When PCI Is Delayed

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Routine IVUS in Peripheral Interventions Supported by Small RCT

IVUS-Guided PCI Tied to Better Long-term Outcomes After Acute MI

Cardiac Deaths and Adverse Events After PCI Have Declined With Time

DCB Match DES for Treating Coronary In-Stent Restenosis: European Registry

‘Aggressive’ OCT Strategy for Stent Sizing Noninferior to IVUS: iSIGHT

No Harm, No Help With Bioabsorbable-Polymer Stents: Registry

FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon

Features of Complex CAD Carry Progressive Risk in PCI, Registry Confirms

Registry Supports Paclitaxel DCBs in CLI Patients to 2 Years

Black Patients in RCTs of PCI Show Worse Long-term Outcomes

Abre Venous Stent Meets 30-Day, 1-Year Targets in Pivotal IDE Trial

Impella in High-risk Nonemergent PCI: Early Differences Disappear by 1 Year

In CAD, No Long-term Safety Signal for Paclitaxel DCBs: Meta-analysis

Balloon-Free PCI for SVG Stenosis Offers Ongoing Advantages: DIVA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content